MedTrace Logo

A Retrospective Study Evaluating the Use of the SoloPath® Sheath in Reducing Vascular and Bleeding Complications

NCT02297308 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2016-02-18

Study results available
· View outcomes & findings →

Summary

This study is a retrospective, single center data collection to assess bleeding and vascular complications associated with TAVI when a SoloPath® Balloon Expandable TransFemoral Introducer is used for vascular access.

Conditions

  • Vascular Access Complication

Sponsors & Collaborators

  • Montreal Heart Institute

    collaborator OTHER

  • Terumo Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Anita Asagr, M.D. · Montreal Heart Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-03-31
Completion
2015-04-30

Countries

  • Canada

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02297308 on ClinicalTrials.gov